Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:17   Issue: 7
Pp: 585-585
William Cho
DOI: 10.2174/156800961707170809143435



Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

Volume:17   Issue: 7
Pp: 603-616
Nishi Karunasinghe*, Jonathan Masters, Jack U. Flanagan and Lynnette R. Ferguson
DOI: 10.2174/1568009617666170330115722




Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

Volume:17   Issue: 7
Pp: 617-636
Subhash Mohan Agarwal*, Divyani Pal, Mansi Gupta and Ravi Saini
DOI: 10.2174/1568009617666170330112842




HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open access plus

Volume:17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI: 10.2174/1568009617666170330120452




The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma

Volume:17   Issue: 7
Pp: 650-656
Giulia Bellini, Daniela Di Pinto, Chiara Tortora, Iolanda Manzo, Francesca Punzo, Fiorina Casale and Francesca Rossi*
DOI: 10.2174/1568009616666161215163426




Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An In Silico Approach

Volume:17   Issue: 7
Pp: 657-668
Farzaneh Mohamadi Farsani, Mohamad Reza Ganjalikhany and Sadeq Vallian*
DOI: 10.2174/1568009617666161109142629



Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP

Volume:17   Issue: 7
Pp: 669-680
Clayton Wright, Anand Krishnan V. Iyer, Juan S. Yakisich and Neelam Azad*
DOI: 10.2174/1568009617666170315162932